Vistagen Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Vistagen Therapeutics, Inc.
CIK #0001411685
EDGAR Form CIK 2011 - 2025
10-K [0001411685]
10-Q [0001411685]
3 [0001411685]
4 [0001411685]
8-K [0001411685]
D [0001411685]
SC 13D [0001411685]
SC 13G [0001411685]
Form 13D/13G Filer Form 13D/13G Subject Filed
Nantahala Capital Management LLC Vistagen Therapeutics Inc [2024-02-14]
Vanguard Group Inc Vistagen Therapeutics Inc [2024-02-13]
Stempoint Capital LP Vistagen Therapeutics Inc [2024-02-12]
TCG Crossover GP II LLC Vistagen Therapeutics Inc [2023-10-16]
Biotechnology Value Fund L P Vistagen Therapeutics Inc [2023-10-16]
Citadel Advisors LLC Vistagen Therapeutics Inc [2023-10-16]
Great Point Partners LLC Vistagen Therapeutics Inc [2023-10-12]
Point72 Asset Management LP Vistagen Therapeutics Inc [2023-10-05]
Commodore Capital LP Vistagen Therapeutics Inc [2023-08-09]
Commodore Capital LP Vistagen Therapeutics Inc [2022-04-14]
View All
Form 3/4/5 Subject 2011 - 2025
Anderson Cynthia Lynn
Vistagen Therapeutics, Inc.
Prince Joshua S.
Adler Reid G.
Singh Shawn
Cote Elissa S.
FitzPatrick Margaret M
GIN Jerry B
Curley Joanne
Cunningham Ann Michelle
View All
Terms | Privacy | Guide
tony@aum13f.com